Related Experiment Videos
Cervical ripening with dehydroepiandrosterone sulphate
British Journal of Obstetrics and Gynaecology
|March 1, 1982
Summary
Intravenous dehydroepiandrosterone sulphate (DHEA-S) effectively ripens the cervix and shortens labor duration in nulliparous women. This safe treatment shows promise for inducing labor in late pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Endocrinology
Background:
- Cervical ripening is crucial for labor induction.
- Dehydroepiandrosterone sulphate (DHEA-S) is a precursor hormone with potential roles in reproductive processes.
Purpose of the Study:
- To evaluate the efficacy and safety of intravenous DHEA-S for cervical ripening and labor induction in term pregnancy.
Main Methods:
- A randomized controlled trial involving nulliparous and parous women at or after 38 weeks gestation.
- Intravenous DHEA-S administered twice weekly, with cervical assessment via Bishop score.
- Comparison with a placebo group.
Main Results:
- Significantly greater Bishop score increase in nulliparous women receiving DHEA-S compared to placebo.
- Improved cervical dilatation, effacement, and consistency in nulliparous women.
- Shortened labor duration and reduced interval to labor onset in nulliparous women.
- DHEA-S showed significant effect on cervical consistency in parous women, but not on labor duration.
Conclusions:
- Intravenous DHEA-S is a safe and effective method for cervical ripening and labor induction in nulliparous women.
- DHEA-S may be a viable option for managing late-term pregnancies requiring induction.